Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
post-traumatic stress disorder
Biotech
Compass shows safety in first psilocybin trial for PTSD
Compass Pathways has reported phase 2 safety data from the first clinical trial of psilocybin in post-traumatic stress disorder (PTSD).
James Waldron
Dec 20, 2023 7:26am
Bionomics' midphase PTSD clinical trial hits primary endpoint
Sep 28, 2023 7:08am
Aptinyx dumps dementia drug, stops PTSD trial after phase 2 flop
Feb 28, 2023 6:15am
